Search - tctmd.com

Displaying 901 - 920 of 1786

Sort: Relevancy | Date

News Industry News

St. Jude Medical Announces CE Mark Approval and First Use of the FlexAbility Ablation Catheter

July 22, 2014

Presentation LAA 2014

Determination of Success, Residual Leaks and Complications

Presenter: Rebecca T. Hahn

July 19, 2014

Presentation

Factors Associated with Vascular Complications in Balloon-Expandable Transfemoral TAVR via Open vs Percutaneous Approaches

Presenter: M.B. Kadakia

July 18, 2014

Presentation LAA 2014

Electrical Approaches to AF Ablation: Acute & Sustained Success, Complications

Presenter: Vivek Y. Reddy

July 17, 2014

News Daily News

经桡动脉PCI会提高NSTEMI患者的长期存活率

Todd Neale

July 17, 2014

News Daily News

Transradial PCI May Improve Long-term Survival in NSTEMI

Todd Neale

July 17, 2014

News Daily News

PARTNER分析体现了TAVR后死亡率曲线

Caitlin E. Cox

July 17, 2014

News Daily News

PARTNER Analyses Highlight Mortality Curves After TAVR

Caitlin E. Cox

July 17, 2014

News Daily News

PARTNER Analiza las Curvas de Mortalidad Post-TAVR Más Destacadas

Caitlin E. Cox

July 17, 2014

News Daily News

Long-term Survival After PCI for CTO Linked with Procedural Success, Completeness of Revascularization

Yael L. Maxwell

July 17, 2014

News Daily News

Las PCI Transradiales Podrían Mejorar la Supervivencia a Largo Plazo en los Cuadros de STEMI

Todd Neale

July 17, 2014

News Daily News

Higher-Volume Operators of Carotid Stenting Reap Better Outcomes, Lower Costs

L.A. McKeown

July 17, 2014

News Daily News

EVAR Results in Higher Patient-Level Safety Benefit than Surgery for AAA

L.A. McKeown

July 17, 2014

Presentation

Radial vs Femoral Access Associated with Reduced Complications and Mortality in NSTEMI Patients

Presenter: M. Iqbal

July 16, 2014

News Daily News

Patient Traits Predict Need for Permanent Pacemaker After TAVR

Yael L. Maxwell

July 10, 2014

News Daily News

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

July 10, 2014

News Daily News

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

July 10, 2014

News Industry News

Covidien Launches EverFlex™ Self-expanding Peripheral Stent with Entrust™ Delivery System in Australia and New Zealand

July 10, 2014

News Industry News

Covidien Launches Next-Generation Trellis™ Peripheral Infusion System

July 08, 2014

News Industry News

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

July 07, 2014

Advertisement

St. Jude Medical Announces CE Mark Approval and First Use of the FlexAbility Ablation Catheter

Determination of Success, Residual Leaks and Complications

Factors Associated with Vascular Complications in Balloon-Expandable Transfemoral TAVR via Open vs Percutaneous Approaches

Electrical Approaches to AF Ablation: Acute & Sustained Success, Complications

经桡动脉PCI会提高NSTEMI患者的长期存活率

Transradial PCI May Improve Long-term Survival in NSTEMI

PARTNER分析体现了TAVR后死亡率曲线

PARTNER Analyses Highlight Mortality Curves After TAVR

PARTNER Analiza las Curvas de Mortalidad Post-TAVR Más Destacadas

Long-term Survival After PCI for CTO Linked with Procedural Success, Completeness of Revascularization

Las PCI Transradiales Podrían Mejorar la Supervivencia a Largo Plazo en los Cuadros de STEMI

Higher-Volume Operators of Carotid Stenting Reap Better Outcomes, Lower Costs

EVAR Results in Higher Patient-Level Safety Benefit than Surgery for AAA

Radial vs Femoral Access Associated with Reduced Complications and Mortality in NSTEMI Patients

Patient Traits Predict Need for Permanent Pacemaker After TAVR

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

Covidien Launches EverFlex™ Self-expanding Peripheral Stent with Entrust™ Delivery System in Australia and New Zealand

Covidien Launches Next-Generation Trellis™ Peripheral Infusion System

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content